What is the NOAEL for Cyclotetrapeptide-24 Aminocyclohexane Carboxylate?
Cyclotetrapeptide-24 Aminocyclohexane Carboxylate has 4 NOAEL studies in the database. The lowest reported value is NR327745KQ UNII. Source: openFDA substances.
CAS 197172-76-2
Cyclotetrapeptide-24 Aminocyclohexane Carboxylate (CAS 197172-76-2) is a chemical substance. Key regulatory status: cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat.
View cosmetic safety profile for Cyclotetrapeptide-24 Aminocyclohexane Carboxylate →
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| NR327745KQ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| NR327745KQ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| NR327745KQ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| NR327745KQ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
Showing 4 of 4 studies
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Cyclotetrapeptide-24 Aminocyclohexane Carboxylate has 4 NOAEL studies in the database. The lowest reported value is NR327745KQ UNII. Source: openFDA substances.
Yes, Cyclotetrapeptide-24 Aminocyclohexane Carboxylate is also indexed as a cosmetic ingredient under the name Cyclotetrapeptide-24 Aminocyclohexane Carboxylate. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Cyclotetrapeptide-24 Aminocyclohexane Carboxylate also appears in cosmetics, pharmaceutical databases.